Top articles this week include another SciX interview with, using Raman imaging to measure the impact of glucose on cancer cells, and diagnosing brain disorders.
Researchers have used Raman spectroscopy and chemometric methods to reveal how glucose affects normal and cancerous brain cell metabolism. Their findings highlight specific biomarkers that can distinguish metabolic changes, potentially aiding in cancer research and treatment.
A recent research collaboration with scientists from Virginia examined using Raman spectroscopy in veterinary medicine to help detect cancer in dogs using urinary screening tests.
Recent research highlights the potential of liquid biopsy combined with Raman spectroscopy (RS) in diagnosing brain disorders. These innovative techniques offer non-invasive, precise, and continuous monitoring capabilities, presenting a promising future for early detection and intervention in conditions such as neurodegenerative diseases (NDs) and traumatic brain injury (TBI).
In this study, a glycerol-fed, lab-scale E. coli bioprocess producing representative pharmaceutical compounds was monitored offline with a portable, high-sensitivity Raman spectrometer.